Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
498 studies found for:    Open Studies | "Anemia"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Anemia"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Study of Romiplostim(AMG531) in Subjects With Aplastic Anemia
Condition: Aplastic Anemia
Intervention: Biological: Romiplostim
2 Not yet recruiting Use of Cast Iron Pots to Improve Maternal Anemia
Condition: Iron-deficiency Anemia
Intervention: Device: Cast Iron Pot
3 Recruiting Hematopoietic Stem Cell Transplantation in High Risk Patients With Fanconi Anemia
Condition: Fanconi Anemia
Interventions: Biological: anti-thymocyte globulin;   Biological: filgrastim;   Drug: busulfan;   Drug: cyclophosphamide;   Drug: fludarabine phosphate;   Drug: methylprednisolone;   Biological: Hematopoietic stem cell transplantation
4 Recruiting Longitudinal Changes in Exercise Capacity in Children and Young Adults With Sickle Cell Anemia
Condition: Sickle Cell Anemia
Intervention:
5 Recruiting Cytoxan, Fludara, and Antithymocyte Globulin Conditioning Followed By Stem Cell Transplant in Treating Fanconi Anemia
Condition: Fanconi Anemia
Interventions: Biological: anti-thymocyte globulin;   Drug: cyclophosphamide;   Drug: fludarabine phosphate;   Procedure: hematopoietic stem cell transplantation;   Drug: methylprednisolone;   Drug: filgrastim;   Drug: cyclosporine;   Drug: Mycophenolate Mofetil
6 Recruiting Allogeneic Stem Cell Transplantation for Patients With Severe Aplastic Anemia
Condition: Anemia, Aplastic
Intervention: Drug: Cyclophosphamide,Campath IH and TBI
7 Recruiting Efficacy and Safety of Eltrombopag + CSA in Patients With Moderate Aplastic Anemia (EMAA)
Condition: Anemia, Aplastic
Interventions: Drug: Eltrombopag;   Drug: Placebo (for Eltrombopag)
8 Recruiting Preoperative Intravenous Iron to Treat Anaemia in Major Surgery
Condition: Anaemia
Interventions: Drug: Ferric carboxymaltose;   Drug: Normal saline
9 Recruiting Quercetin in Children With Fanconi Anemia; a Pilot Study
Condition: Fanconi Anemia
Intervention: Drug: Quercetin (dietary supplement)
10 Recruiting Safety and Efficacy Study of Roxadustat to Treat Anemia in Patients With Chronic Kidney Disease, on Dialysis
Condition: Anemia
Interventions: Drug: Roxadustat;   Drug: Epoetin alfa
11 Recruiting Intravenous Iron for Treatment of Anaemia Before Cardiac Surgery
Condition: Anaemia
Interventions: Drug: Ferric carboxymaltose;   Drug: Placebo
12 Recruiting Safety and Efficacy of Exjade in the Treatment of Transfusion-dependent Iron Overload in Aplastic Anemia Patients
Condition: Aplastic Anemia
Interventions: Drug: ICL670A and standard immunosupressive therapy (Cyclosporine A);   Drug: Immunosupressive therapy (Cyclosporine A)
13 Recruiting Safety and Efficacy of Patient's Own AD-MSC and AD-HSC Transplantation in Patients With Severe Aplastic Anemia
Condition: Severe Aplastic Anemia
Interventions: Drug: Rabbit antithymoglobulin (ATG);   Procedure: Adipose derived mesenchymal stem cells ( AD-MSCs);   Procedure: AD-MSC transdifferentiated HSCs (AD-HSCs)
14 Recruiting Safety and Efficacy Study of Sotatercept in Adults With Transfusion Dependent Diamond Blackfan Anemia
Condition: Diamond Blackfan Anemia
Interventions: Drug: Sotatercept;   Drug: Sotatercept with prednisone boost
15 Recruiting Comparison of Two Different Doses of Rabbit ATG-Fresenius With Cyclosporin in the Treatment of Acquired Aplastic Anaemia
Condition: Aplastic Anemia
Intervention: Drug: ATG-fresenius
16 Recruiting A Phase II Trial of Regadenoson in Sickle Cell Anemia
Condition: Sickle Cell Anemia
Interventions: Drug: Regadenoson;   Drug: Placebo
17 Not yet recruiting Clinical Signs and Symptoms of Anemia in Patients Over 75 Years
Condition: Anemia
Intervention:
18 Recruiting Biosimilar Erythropoietin in Anaemia Treatment (Correction Phase Study)
Condition: Renal Anaemia
Interventions: Drug: EPIAO®;   Drug: EPREX®
19 Recruiting Effect of Ejiao Compound in the Treatment of Postpartum Anemia of Qi-blood Deficiency Syndrome
Condition: Postpartum Anemia
Interventions: Drug: Ejiao compound;   Drug: Niferex
20 Recruiting The Congenital Dyserythropoietic Anemia Registry (CDAR)
Condition: Congenital Dyserythropoietic Anemia (CDA)
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.